Literature DB >> 1676921

Torsades de pointes complicating treatment with terfenadine.

T J MacConnell, A J Stanners.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1676921      PMCID: PMC1670151          DOI: 10.1136/bmj.302.6790.1469-b

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  3 in total

1.  Cardiotoxic effect with convulsions in terfenadine overdose.

Authors:  A J Davies; V Harindra; A McEwan; R R Ghose
Journal:  BMJ       Date:  1989-02-04

2.  Astemizole-induced torsade de pointes.

Authors:  F E Simons; M S Kesselman; N G Giddins; A N Pelech; K J Simons
Journal:  Lancet       Date:  1988-09-10       Impact factor: 79.321

3.  Torsade de pointes after astemizole overdose.

Authors:  T M Craft
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-08
  3 in total
  12 in total

1.  Second-generation antihistamines: a comparative review.

Authors:  J W Slater; A D Zechnich; D G Haxby
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

Review 2.  Towards a better understanding of QT interval variability.

Authors:  Larisa G Tereshchenko; Ronald D Berger
Journal:  Ther Adv Drug Saf       Date:  2011-12

3.  Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs.

Authors:  F J de Abajo; L A Rodríguez
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

4.  Torsades de pointes after terfenadine-itraconazole interaction.

Authors:  S Pohjola-Sintonen; M Viitasalo; L Toivonene; P Neuvonen
Journal:  BMJ       Date:  1993-01-16

Review 5.  Terfenadine. The first nonsedating antihistamine.

Authors:  H C Masheter
Journal:  Clin Rev Allergy       Date:  1993

Review 6.  Inhibition of terfenadine metabolism. Pharmacokinetic and pharmacodynamic consequences.

Authors:  K T Kivistö; P J Neuvonen; U Klotz
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447

7.  Evaluation of the pharmacokinetics and electrocardiographic pharmacodynamics of loratadine with concomitant administration of ketoconazole or cimetidine.

Authors:  T Kosoglou; M Salfi; J M Lim; V K Batra; M N Cayen; M B Affrime
Journal:  Br J Clin Pharmacol       Date:  2000-12       Impact factor: 4.335

8.  Itraconazole prevents terfenadine metabolism and increases risk of torsades de pointes ventricular tachycardia.

Authors:  S Pohjola-Sintonen; M Viitasalo; L Toivonen; P Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  Possible interactions with terfenadine or astemizole.

Authors:  A D Zechnich; J R Hedges; D Eiselt-Proteau; D Haxby
Journal:  West J Med       Date:  1994-04

Review 10.  The role of active metabolites in drug toxicity.

Authors:  M Pirmohamed; N R Kitteringham; B K Park
Journal:  Drug Saf       Date:  1994-08       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.